Mutual antagonism between indoleamine 2,3-dioxygenase 1 and nuclear factor E2-related factor 2 regulates the maturation status of DCs in liver fibrosis
- 6 August 2020
- journal article
- research article
- Published by Elsevier BV in Free Radical Biology & Medicine
- Vol. 160, 178-190
- https://doi.org/10.1016/j.freeradbiomed.2020.07.038
Abstract
No abstract availableFunding Information
- Guangzhou Municipal Science and Technology Project
- Guangdong Provincial Applied Science and Technology Research and Development Program
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Science and Technology Planning Project of Guangdong Province
- National Natural Science Foundation of China
- Southern Medical University
This publication has 49 references indexed in Scilit:
- Liver inflammation and fibrosisJCI Insight, 2017
- The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cellsOncotarget, 2016
- Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cellsNeuropharmacology, 2015
- The Epidemiology of Cirrhosis in the United StatesJournal of Clinical Gastroenterology, 2015
- High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse liversNature Protocols, 2015
- Intracellular accumulation of subviral HBsAg particles and diminished Nrf2 activation in HBV genotype G expressing cells lead to an increased ROI levelJournal of Hepatology, 2014
- Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysisBMC Medicine, 2014
- Nuclear Factor-erythroid 2 (NF-E2) p45-related Factor-2 (Nrf2) Modulates Dendritic Cell Immune Function through Regulation of p38 MAPK-cAMP-responsive Element Binding Protein/Activating Transcription Factor 1 SignalingOnline Journal of Public Health Informatics, 2013
- Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regressionJournal of Hepatology, 2011
- Selective inhibition of IDO1 effectively regulates mediators of antitumor immunityBlood, 2010